Ignite Creation Date:
2025-12-25 @ 4:46 AM
Ignite Modification Date:
2026-05-30 @ 12:16 PM
Study NCT ID:
NCT01804218
Status:
UNKNOWN
Last Update Posted:
2016-08-09
First Post:
2013-03-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
Sponsor:
Invion, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
U01-BCM-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None